Nilotinib (inkl. orale Verabreichung dispergiert in Apfelmus)_TK, HEK, hkk

TENDER DESCRIPTION

Health insurance funds pursue the goal of concluding discount contracts pursuant to Section 130a(8) of SGB V with all suitable pharmaceutical entrepreneurs for the active substances, active substance combinations and/or dosage forms, strengths, or finished medicinal products stated in the respective lot. The following active substances, active substance combinations and/or dosage forms, strengths, or finished medicinal products form part of the present procedure (for details, see information provided in the titles of the respective lots): Betamethasone/Calcipotriol (CRE) Clobazam (liquid oral DRF) Clotrimazole (Rx: vaginal DRF) Mercaptopurine (FAM: solid oral DRF) Methyldopa (250 mg (N3)) Nilotinib (except oral administration dispersed in apple sauce) Nilotinib (including oral administration dispersed in apple sauce) Oxybutynin (PFT) Perindopril erbumine/Indapamide (90 St.) Perindopril/Indapamide (except Perindopril erbumine) Piribedil Pomalidomide Raltegravir (except GSE, KTA) Risperidone (solid oral DRF: 0.25 mg) Tranylcypromine Oxybutynin (LIV)

TENDER BRIEF

TENDER DOCUMENTS